Glenveigh Medical™ is a science and technology-based company focused on advancing the practice of obstetrics. Founded in 2004 by C. David Adair, MD, a maternal-fetal medicine (MFM) specialist, Glenveigh has grown into an attractive partner for physicians with innovative ideas, and has a steady flow of opportunities.

MDDG is working as the commercialization partner for Glenveigh Medical, with active projects in all phases from concept review to clinical trials. In this capacity, MDDG is responsible for human factors, regulatory compliance, supply chain, technology development and transfer, risk management, and supporting activities such as QSR and new opportunity review.

Atlanta Catheter Therapies, Inc. (ACT™) is an early stage medical device company with an innovative targeted portfolio of technologies for the treatment of vascular disease.  The company is developing an innovative and highly proprietary system of endovascular debulking (clearing of blocked blood vessels) devices including a revolutionary universal drug delivery system to minimize restenosis (re-blockage).

MDDG is working with Atlanta Catheter Therapies, Inc. co-founders by taking their idea from concept to fruition.  In addition, MDDG is providing a highly experienced healthcare executive to serve as chief executive office on an interim basis.

Medical College of Georgia
The Office of Technology Transfer and Economic Development (OTTED) is designed to help faculty, staff and student researchers with their inventions by serving as a resource on matters related to intellectual property. Our goal is to transform inventions into protected intellectual property which can become new products and services destined to improve health care and the quality of life for the people of the state and for society in general, while fostering teaching, research and service at MCG.

MDDG hosted a brainstorming session with the inventor and tech transfer principals from MCG and was able to identify several potential applications for their intellectual property.  MDDG then developed a “proof-of-concept” device based on the application that was determined to be most attractive to commercialize.

TCP Technology
TCP Technology was founded for the express purpose of developing unusual revolutionary visualization and software techniques for catheter based devices. Current products under development focus on methods to measure blood flow velocity, pressure gradients, stenosis analyses, and visualization of the internal wall of arteries uninhibited by blood flow. This will allow constant visualization of the vessel wall through 360 degrees in real time as the catheter is moved in and out of the vessel.
 

MDDG has developed a prototype catheter for TCP Technologies based on their requirements.